Status: current, Primitive. Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3786598017 | Relebactam (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3786599013 | Relebactam | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Relebactam | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Relebactam | Is a | Antibacterial | true | Inferred relationship | Some | ||
| Relebactam | Is a | Substance with beta-lactamase inhibitor mechanism of action | true | Inferred relationship | Some | ||
| Relebactam | Has disposition | Antibacterial | true | Inferred relationship | Some | ||
| Relebactam | Is a | Azabicyclo compound | true | Inferred relationship | Some | ||
| Relebactam | Has disposition | Beta-lactamase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cilastatin- and imipenem- and relebactam-containing product | Has active ingredient | True | Relebactam | Inferred relationship | Some | 2 |
| Cilastatin and imipenem and relebactam only product | Has active ingredient | True | Relebactam | Inferred relationship | Some | 2 |
| Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Has active ingredient | True | Relebactam | Inferred relationship | Some | 2 |
| Cilastatin and imipenem and relebactam only product in parenteral dose form | Has active ingredient | True | Relebactam | Inferred relationship | Some | 2 |
| Relebactam monohydrate | Is modification of | True | Relebactam | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR